Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 2Vitamin D Deficiency 1Stroke 1Spinal Cord Injuries 1Seizures 1Polyps 1Neoplasms 1Musculoskeletal Diseases 1Meningitis 1Intracranial Hemorrhages 1Intracranial Aneurysm 1Critical Illness 1Craniocerebral Trauma 1Colorectal Neoplasms 1Brain Neoplasms 1Adenomatous Polyps 1Adenoma 1

Interventions

Lomustine 2Gefitinib 2Carboplatin 2trofosfamide 1tozuleristide 1entrectinib 1Vincristine 1Thiotepa 1Temozolomide 1Sunitinib 1Radiotherapy 1Methylprednisolone 1Maintenance Chemotherapy 1Magnetic Resonance Spectroscopy 1Induction Chemotherapy 1Etoposide 1Erlotinib Hydrochloride 1Diploidy 1Dexamethasone 1Cyclophosphamide 1Cisplatin 1Cholecalciferol 1Bevacizumab 1Adrenal Cortex Hormones 1AZD3759 12-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Brain Neoplasms × Cholecalciferol × Clear all
NCT02881957 2022-06-15

Hypovitaminosis D in Neurocritical Patients

University of Utah

Phase 2/3 Completed
274 enrolled 16 charts
CNS

Brain Neoplasms, Intracranial Aneurysm, Craniocerebral Trauma, Meningitis, Seizures, Spinal Cord Injuries, Vitamin D Deficiency, Critical Illness, Intracranial Hemorrhages, Stroke

Data powered by HemOnc (CC BY 4.0) Colophon âš¡